We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Philips to Acquire Leading Brazilian Critical Care Company

By HospiMedica staff writers
Posted on 13 May 2008
In a move that further bolsters its strategy of penetrating high-growth emerging critical care markets by way of economically priced devices, Netherlands-based Royal Philips Electronics announced its agreement to acquire Dixtal Biomédica e Tecnologia, a leading Brazilian manufacturer of patient monitoring and critical care devices.

Dixtal (São Paulo, Brazil) is a leading Brazilian manufacturer of in-hospital patient monitoring, anesthesia, ventilation, and ECG (Electrocardiogram) equipment as well as other sensors for vital sign measurements. More...
Dixtal will become part of the Patient Monitoring business within Philips' Healthcare sector. Philips expects Dixtal's financial results to be consolidated as of the third quarter of 2008. The terms of the deal were not disclosed.

The announcement marks another step Philips (Amsterdam, The Netherlands) is taking to expand its presence in high-growth healthcare markets in emerging economies, following the company's earlier announced acquisitions of healthcare companies Shenzhen Goldway in China and VMI Sistemas Medicos in Brazil.

In commenting on the deal, Mr. Daurio Speranzini Júnior, Senior Vice-President of Philips Healthcare Latin America, said: "Emerging markets represent a real opportunity for us to keep growing our healthcare business at Philips. If you just take Latin America, our segment of the healthcare market in 2007 was estimated to be valued at approximately EUR 1.2 billion, and growing at twice the rate of developed markets. Acquiring Dixtal will help us further tap into that growth.”

Mr. Speranzini Júnior continued, "In the hospital, a key component of critical care is patient monitoring, and Philips already enjoys a leading global position in this market. Acquiring Dixtal will not only extend Philips' product portfolio to include Dixtal's mid- to economy-range patient monitoring products, but through this move we'll gain access to other key components of critical care – Dixtal's anesthesia machines and its invasive ventilation products. Accordingly, this acquisition complements Philips' recent move into the non-invasive ventilation business through our acquisition earlier this year of US-based Respironics. And since Dixtal and Philips use the same distribution channels vis-à-vis hospitals for all of our critical care businesses, we can expect significant synergies coming out of this collaboration.”

Founded in 1978, Dixtal is a privately held healthcare company headquartered in São Paulo, Brazil. Dixtal employs approximately 300 people, mainly in Brazil, of which 60 work in R&D. "Since being founded 30 years ago, we've focused on helping hospitals provide the optimum in critical care. We believe that combining our culture and capabilities with those of a world class company like Philips will help us serve society better and expand our presence in Latin America and beyond,” said Albert Holzhacker, President of Dixtal.

Over the last four years, Dixtal has tripled its revenues. Following completion of the acquisition, growth is expected to accelerate further as Philips leverages Dixtal's contacts with local hospitals and distributors, while Dixtal capitalizes on Philips' global presence for its products.

Philips has an extensive presence in critical care through its leading position in the global patient monitoring market, which in 2007 was estimated at approximately EUR 2 billion.


Related Links:
Dixtal
Philips

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.